Markets:

Overview

News

Currencies

International

Treasuries

Privia Health Group, Inc. - Common Stock (NQ:PRVA)

22.44 -0.27 (-1.19%)

Streaming Delayed Price Updated: 10:37 AM EDT, Apr 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Privia Health Group, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

1 of Wall Street’s Favorite Stock to Research Further and 2 to Steer Clear Of

April 09, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

Medicare Advantage Rates Expected To Climb Over 5% In 2026, Easing Pressure On Managed Care ↗

April 08, 2025

CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers focused on value-based care.

Via Benzinga

How Is The Market Feeling About Privia Health Gr? ↗

April 07, 2025

Via Benzinga

2 Reasons to Sell PRVA and 1 Stock to Buy Instead

April 02, 2025

Even during a down period for the markets, Privia Health has gone against the grain, climbing to $22.91. Its shares have yielded a 29.3% return over the last six months, beating the S&P 500 by 30.9%....

Via StockStory

Topics Stocks Supply Chain

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

What Analysts Are Saying About Privia Health Gr Stock ↗

February 14, 2025

Via Benzinga

A Glimpse Into The Expert Outlook On Privia Health Gr Through 6 Analysts ↗

January 02, 2025

Via Benzinga

1 Healthcare Stock with Solid Fundamentals and 2 to Ignore

March 28, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Stocks

Breaking Down Privia Health Gr: 10 Analysts Share Their Views ↗

March 21, 2025

Via Benzinga

Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR)

March 14, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Phreesia (NYSE:PHR) and its peers.

Via StockStory

Phreesia (PHR) To Report Earnings Tomorrow: Here Is What To Expect

March 11, 2025

Healthcare technology company Phreesia (NYSE:PHR) will be reporting results tomorrow after the bell. Here’s what to look for.

Via StockStory

Key Takeaways From Privia Health Gr Analyst Ratings ↗

August 14, 2024

Via Benzinga

Forecasting The Future: 7 Analyst Projections For Privia Health Gr ↗

July 09, 2024

Via Benzinga

What 12 Analyst Ratings Have To Say About Privia Health Gr ↗

May 15, 2024

Via Benzinga

3 Stocks Under $50 Walking a Fine Line

March 07, 2025

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and...

Via StockStory

Privia Health (NASDAQ:PRVA) Surprises With Q4 Sales But Full-Year Sales Guidance Misses Expectations

February 27, 2025

Healthcare tech company Privia Health Group (NASDAQ:PRVA) announced better-than-expected revenue in Q4 CY2024, with sales up 4.6% year on year to $460.9 million. On the other hand, the company’s...

Via StockStory

Privia Health (PRVA) Q4 Earnings Report Preview: What To Look For

February 26, 2025

Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be announcing earnings results tomorrow before market open. Here’s what to expect.

Via StockStory

Insiders Buying Hilton Worldwide And 2 Other Stocks ↗

May 30, 2024

Via Benzinga

Where Privia Health Gr Stands With Analysts ↗

April 22, 2024

Via Benzinga

Analyst Scoreboard: 8 Ratings For Privia Health Gr ↗

March 19, 2024

Via Benzinga

Forecasting The Future: 4 Analyst Projections For Privia Health Gr ↗

February 29, 2024

Via Benzinga

Earnings Scheduled For February 27, 2024 ↗

February 27, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.

Via Benzinga

PRVA Stock Earnings: Privia Health Gr Beats EPS, Misses Revenue for Q1 2024 ↗

May 09, 2024

PRVA stock results show that Privia Health Gr beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

JP Morgan Maintains Overweight Rating for Privia Health Gr: Here's What You Need To Know ↗

March 06, 2024

Via Benzinga

Privia Health Gr's Earnings: A Preview ↗

February 26, 2024

Via Benzinga

B of A Securities Downgrades Privia Health Gr: Here's What You Need To Know ↗

February 22, 2024

Via Benzinga

Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 29, 2024

Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped...

Via Benzinga

Preview: Privia Health Gr's Earnings ↗

November 02, 2023

Via Benzinga

Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday ↗

November 03, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Earnings Scheduled For November 3, 2023 ↗

November 03, 2023

Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.